In this issue
Article tools
Canadian study of health and aging: study methods and prevalence of dementia
Related Articles
Cited By...
- Impact of the Quebec Alzheimer Plan on the detection and management of Alzheimer disease and other neurocognitive disorders in primary health care: a retrospective study
- Probing the network structure of health deficits in human aging
- Prevalence and management of dementia in primary care practices with electronic medical records: a report from the Canadian Primary Care Sentinel Surveillance Network
- Utility of Hippocrates' prognostic aphorism to predict death in the modern era: prospective cohort study
- Subtle Post-Procedural Cognitive Dysfunction After Atrial Fibrillation Ablation
- Neuropathologic features associated with Alzheimer disease diagnosis: Age matters
- Care and outcomes in patients with ischemic stroke with and without preexisting dementia
- Nontraditional risk factors combine to predict Alzheimer disease and dementia
- Communicating with families of dementia patients: Practical guide to relieving caregiver stress
- Impact of Androgen-Deprivation Therapy on Cognitive Function in Men With Nonmetastatic Prostate Cancer
- Omega-3 fatty acids and risk of dementia: the Canadian Study of Health and Aging
- Does a single-item measure of depression predict mortality?
- Does Executive Function Explain the IQ-Mortality Association? Evidence from the Canadian Study on Health and Aging
- Diagnosis and treatment of dementia: 6. Management of severe Alzheimer disease
- No advantage of A{beta}42-lowering NSAIDs for prevention of Alzheimer dementia in six pooled cohort studies
- Diagnosis and treatment of dementia: Introduction. Introducing a series based on the Third Canadian Consensus Conference on the Diagnosis and Treatment of Dementia
- Joint effect of stroke and APOE 4 on dementia risk: The Canadian Study of Health and Aging
- Cerebrovascular disease and dementia
- Losing your mind
- Preclinical Vascular Cognitive Impairment and Alzheimer Disease: Neuropsychological Test Performance 5 Years Before Diagnosis
- Maladie d'Alzheimer
- Dropouts and refusals in observational studies: Lessons for prevention trials.
- Predictors of driving cessation in mild-to-moderate dementia.
- Brain estrogen deficiency accelerates A{beta} plaque formation in an Alzheimer's disease animal model
- A global clinical measure of fitness and frailty in elderly people
- Apolipoprotein E {epsilon}4 genotype as a risk factor for cognitive decline and dementia: data from the Canadian Study of Health and Aging
- Homocysteine and cognitive function in elderly people
- Variations in case definition affect prevalence but not outcomes of mild cognitive impairment
- Efficacy and safety of cholinesterase inhibitors in Alzheimer's disease: a meta-analysis
- Combination hormone replacement therapy and dementia
- Knowledge of the legislation governing proxy consent to treatment and research
- Risperidone (Risperdal): increased rate of cerebrovascular events in dementia trials
- Cognitive Impairment in Heart Failure: Issues of Measurement and Etiology
- The value of clock drawing in identifying executive cognitive dysfunction in people with a normal Mini-Mental State Examination score
- Neuropsychological Predictors of Incident Dementia in Patients With Vascular Cognitive Impairment, Without Dementia
- Societal Costs of Vascular Cognitive Impairment in Older Adults
- Well-Being After Stroke in Canadian Seniors: Findings From the Canadian Study of Health and Aging
- Past exposure to vaccines and subsequent risk of Alzheimer's disease
- Prevalence of cognitive impairment: Data from the Indianapolis Study of Health and Aging
- Assessment of health economics in Alzheimer's disease (AHEAD): Galantamine treatment in Canada
- Progression of impairment in patients with vascular cognitive impairment without dementia
- Practice parameter: Diagnosis of dementia (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology
- Prevalence of AD among whites: A summary by levels of severity
- The incidence of dementia in Canada
- Vascular Dementia : Incidence and Risk Factors in the Canadian Study of Health and Aging
- Incidence and outcomes of diabetes mellitus in elderly people: report from the Canadian Study of Health and Aging
- Prevalence and outcomes of vascular cognitive impairment
- Causes of Alzheimer's disease
- Calcium-channel blockers and cognitive function in elderly people: results from the Canadian Study of Health and Aging
- ApoE genotype in relation to AD and cholesterol: A study of 2,326 Chinese adults
- Mortality in elderly Canadians with and without dementia: A 5-year follow-up
- Interhemispheric disconnection syndrome in Alzheimer's disease
- Relationship Between ApoE, MRI Findings, and Cognitive Function in the Cardiovascular Health Study
- The Canadian Study of Health and Aging : Risk Factors for Vascular Dementia